Investment in Securities | B. Investment in Securities Management determines the appropriate classification of debt and equity securities at the time of purchase and reevaluates such designation as of the date of each consolidated statement of financial condition. Investments in United States Treasury Bills and Notes with maturities of greater than three months at the time of purchase are classified as investments in securities, and those with maturities of three months or less at the time of purchase are classified as cash equivalents. The portion of investments in securities held for resale in anticipation of short-term market movements are classified as trading securities. Trading securities are stated at fair value, with any unrealized gains or losses reported in current period earnings. Available for sale (“AFS”) investments are stated at fair value, with any unrealized gains or losses, net of taxes, reported as a component of equity except for losses deemed to be other-than- temporary (“OTT”) which are recorded as realized losses in the condensed consolidated statements of income. In addition, realized gains and losses from AFS securities are reclassified from equity to current period income. Investments in securities, including GBL stock, at September 30, 2017, December 31, 2016 and September 30, 2016 consisted of the following: September 30, 2017 December 31, 2016 September 30, 2016 Cost Fair Value Cost Fair Value Cost Fair Value (In thousands) Trading securities: Government obligations $ 115,897 $ 116,152 $ 119,755 $ 119,823 $ 24,952 $ 24,995 Common stocks 155,732 172,312 69,503 82,158 64,393 77,031 Mutual funds 2,405 3,633 2,402 3,143 2,384 3,031 Other investments 1,378 1,491 1,275 1,472 696 934 Total trading securities 275,412 293,588 192,935 206,596 92,425 105,991 Available for sale securities: Common stocks 130,869 130,737 150,000 135,701 150,000 125,070 Mutual funds 103 284 206 500 206 481 Total available for sale securities 130,972 131,021 150,206 136,201 150,206 125,551 Total investments in securities $ 406,384 $ 424,609 $ 343,141 $ 342,797 $ 242,631 $ 231,542 Securities sold, not yet purchased at September 30, 2017, December 31, 2016 and September 30, 2016 consisted of the following: September 30, 2017 December 31, 2016 September 30, 2016 Proceeds Fair Value Proceeds Fair Value Proceeds Fair Value Trading securities: (In thousands) Common stocks $ 7,906 $ 8,558 $ 9,583 $ 9,947 $ 3,697 $ 3,948 Other investments 1 501 27 37 245 267 Total securities sold, not yet purchased $ 7,907 $ 9,059 $ 9,610 $ 9,984 $ 3,942 $ 4,215 Investments in affiliated registered investment companies at September 30, 2017, December 31, 2016 and September 30, 2016 consisted of the following: September 30, 2017 December 31, 2016 September 30, 2016 Cost Fair Value Cost Fair Value Cost Fair Value (In thousands) Trading securities: Mutual funds $ 40,095 $ 46,390 $ 40,096 $ 45,351 $ 40,096 $ 44,799 Total trading securities 40,095 46,390 40,096 45,351 40,096 44,799 Available for sale securities: Closed-end funds 65,180 90,516 62,890 80,650 61,375 75,392 Mutual funds 4,384 6,159 4,396 5,644 4,408 6,031 Total available for sale securities 69,564 96,675 67,286 86,294 65,783 81,423 Total investments in affiliated registered investment companies $ 109,659 $ 143,065 $ 107,382 $ 131,645 $ 105,879 $ 126,222 The following table identifies all reclassifications out of accumulated other comprehensive income (“AOCI”) into income for the three and nine months ended September 30, 2017 and 2016 (in thousands): Amount Affected Line Items Reason for Reclassified in the Statements Reclassification from AOCI Of Income from AOCI Three months ended September 30, 2017 2016 $ 125 $ - Net gain/(loss) from investments Realized gain on sale of AFS securities 125 - Income/(loss) before income taxes (45 ) - Income tax provision $ 80 $ - Net income/(loss) Amount Affected Line Items Reason for Reclassified in the Statements Reclassification from AOCI Of Income from AOCI Nine months ended September 30, 2017 2016 $ 167 $ 348 Net gain/(loss) from investments Realized gain on sale of AFS securities (19,131 ) (298 ) Net gain/(loss) from investments OTT impairment of AFS securities (18,964 ) 50 Income/(loss) before income taxes 6,827 (18 ) Income tax provision $ (12,137 ) $ 32 Net income/(loss) The Company recognizes all equity derivatives as either assets or liabilities measured at fair value and includes them in either investments in securities or securities sold, not yet purchased on the condensed consolidated statements of financial condition. From time to time, the Company and/or the partnerships and offshore funds that the Company consolidates will enter into hedging transactions to manage their exposure to foreign currencies and equity prices related to their investments. At September 30, 2017, December 31, 2016 and September 30, 2016, we held derivative contracts on 1.8 million equity shares, 16,000 equity shares and 24,000 equity shares, respectively, that are included in investments in securities or securities sold, not yet purchased on the condensed consolidated statements of financial condition. We had no foreign exchange contracts outstanding at September 30, 2017 and December 31, 2016 and September 30, 2016. Generally, these transactions are not designated as hedges for accounting purposes, and, therefore changes in fair values of these derivatives are included in net gain/(loss) from investments on the condensed consolidated statements of income. The following table identifies the fair values of all derivatives held by the Company (in thousands): Asset Derivatives Liability Derivatives Statement of Fair Value Statement of Fair Value Financial Condition September 30, December 31, September 30, Financial Condition September 30, December 31, September 30, Location 2017 2016 2016 Location 2017 2016 2016 Derivatives designated as hedging instruments under FASB ASC 815-20 Foreign exchange Receivable from contracts brokers $ - $ - $ - Payable to brokers $ - $ - $ - Sub total $ - $ - $ - $ - $ - $ - Derivatives not designated as hedging instruments under FASB ASC 815-20 Equity contracts Investments in Securities sold, securities $ 151 $ 127 $ 178 not yet purchased $ 501 $ 37 $ 33 Foreign exchange Receivable from contracts brokers - - - Payable to brokers - - - Sub total $ 151 $ 127 $ 178 $ 501 $ 37 $ 33 Total derivatives $ 151 $ 127 $ 178 $ 501 $ 37 $ 33 The following table identifies gains and losses of all derivatives held by the Company (in thousands): Type of Derivative Income Statement Location Three Months Ended September 30, Nine Months Ended September 30, 2017 2016 2017 2016 Foreign exchange contracts Net gain/(loss) from investments $ - $ - $ - $ 1,373 Equity contracts Net gain/(loss) from investments (456 ) 159 (490 ) 204 Total $ (456 ) $ 159 $ (490 ) $ 1,577 The Company is a party to enforceable master netting arrangements for swaps entered into with major U.S. financial institutions as part of the investment strategy of the Company’s proprietary portfolio. They are typically not used as hedging instruments. These swaps, while settled on a net basis with the counterparties are shown gross in assets and liabilities on the condensed consolidated statements of financial condition. The swaps have a firm contract end date and are closed out and settled when each contract expires. Gross Amounts Not Offset in the Statements of Financial Condition Gross Gross Amounts Net Amounts of Amounts of Offset in the Assets Presented Recognized Statements of in the Statements of Financial Cash Collateral Assets Financial Condition Financial Condition Instruments Received Net Amount Swaps: (In thousands) September 30, 2017 $ 151 $ - $ 151 $ (151 ) $ - $ - December 31, 2016 96 - 96 (9 ) - 87 September 30, 2016 $ 178 $ - $ 178 $ (14 ) $ - $ 164 Gross Amounts Not Offset in the Statements of Financial Condition Gross Gross Amounts Net Amounts of Amounts of Offset in the Liabilities Presented Recognized Statements of in the Statements of Financial Cash Collateral Liabilities Financial Condition Financial Condition Instruments Pledged Net Amount Swaps: (In thousands) September 30, 2017 $ 500 $ - $ 500 $ (151 ) $ - $ 349 December 31, 2016 9 - 9 (9 ) - - September 30, 2016 $ 14 $ - $ 14 $ (14 ) $ - $ - The following is a summary of the cost, gross unrealized gains, gross unrealized losses and fair value of available for sale investments as of September 30, 2017, December 31, 2016 and September 30, 2016: September 30, 2017 Gross Gross Unrealized Unrealized Cost Gains Losses Fair Value (In thousands) Common stocks $ 130,869 $ - $ (132 ) $ 130,737 Closed-end funds 65,180 25,535 (199 ) 90,516 Mutual funds 4,487 1,956 - 6,443 Total available for sale securities $ 200,536 $ 27,491 $ (331 ) $ 227,696 December 31, 2016 Gross Gross Unrealized Unrealized Cost Gains Losses Fair Value (In thousands) Common stocks $ 150,000 $ - $ (14,299 ) $ 135,701 Closed-end funds 62,890 17,760 - 80,650 Mutual funds 4,602 1,542 - 6,144 Total available for sale securities $ 217,492 $ 19,302 $ (14,299 ) $ 222,495 September 30, 2016 Gross Gross Unrealized Unrealized Cost Gains Losses Fair Value (In thousands) Common stocks $ 150,000 $ - $ (24,930 ) $ 125,070 Closed-end funds 61,375 14,027 (10 ) 75,392 Mutual funds 4,614 1,898 - 6,512 Total available for sale securities $ 215,989 $ 15,925 $ (24,940 ) $ 206,974 Changes in net unrealized gains, net of taxes, for the three months ended September 30, 2017 and September 30, 2016 of $1.7 million in gains and $9.3 million in losses, respectively, have been included in other comprehensive income, a component of equity, at September 30, 2017 and September 30, 2016. Return of capital on available for sale securities was $0.5 million and $0.2 million for the three months ended September 30, 2017 and 2016, respectively. Proceeds from sales of investments available for sale were approximately $0.2 million for the three months ended September 30, 2017. For the three months ended September 30, 2017, gross gains on the sale of investments available for sale amounted to $0.1 million and were reclassified from other comprehensive income into net gain/(loss) from investments in the condensed consolidated statements of income. There were no proceeds from the sales of investments available for sale and no gross gains on the sale of investments available for sale for the three months ended September 30, 2016. There were no losses on the sale of investments available for sale for the three months ended September 30, 2017 or September 30, 2016. Changes in net unrealized gains/(losses), net of taxes, for the nine months ended September 30, 2017 and September 30, 2016 of $14.2 million in gains and $4.8 million in losses, respectively, have been included in other comprehensive income, a component of equity, at September 30, 2017 and September 30, 2016. Return of capital on available for sale securities was $1.3 million and $0.8 million for the nine months ended September 30, 2017 and September 30, 2016, respectively. Proceeds from sales of investments available for sale were approximately $0.3 million and $0.8 million for the nine months ended September 30, 2017 and 2016, respectively. For the nine months ended September 30, 2017 and 2016, gross gains on the sale of investments available for sale amounted to $0.2 million and $0.3 million and were reclassified from other comprehensive income into net gain/(loss) from investments in the condensed consolidated statements of income. There were no losses on the sale of investments available for sale for the nine months ended September 30, 2017 or September 30, 2016. The Company determines the cost of a security sold by using specific identification. Investments classified as available for sale that are in an unrealized loss position for which other-than-temporary impairment has not been recognized consisted of the following (in thousands): September 30, 2017 December 31, 2016 September 30, 2016 Unrealized Unrealized Unrealized Cost Losses Fair Value Cost Losses Fair Value Cost Losses Fair Value Common stocks $ 130,869 $ (132 ) $ 130,737 $ 150,000 $ (14,299 ) $ 135,701 $ 150,000 $ (24,930 ) $ 125,070 Closed-end funds 1,864 (199 ) 1,665 - - - 3,162 (10 ) 3,152 Total available for sale securities in unrealized loss position $ 132,733 $ (331 ) $ 132,402 $ 150,000 $ (14,299 ) $ 135,701 $ 153,162 $ (24,940 ) $ 128,222 There were no losses on AFS securities deemed to be OTT for the three months ended September 30, 2017 and 2016. For the nine months ended September 30, 2017, AC recognized a $19.1 million OTT on the GBL shares due to the magnitude and persistence of the unrealized loss. For the nine months ended September 30, 2016, the Company reflected $0.3 million of losses on AFS securities deemed to be OTT. At September 30, 2017, two holdings with unrealized losses were not deemed to be other-than-temporarily impaired due to the length of time that they had been in a loss position and our evaluation of issuer-specific and industry-specific considerations. One of these investments was a closed-end fund with diversified holdings across multiple companies and industries. This holding was impaired for nine months at September 30, 2017. The second holding was the GBL stock that was, as noted above, deemed to have an “other than temporary impairment” during the nine months ended September 30, 2017, but which has subsequently had further unrealized losses. These further losses were not deemed to be other-than-temporarily impaired. The value of the two holdings at September 30, 2017 was $132.4 million. If these holdings continue to be impaired, we may need to record this impairment in a future period on the condensed consolidated statements of income for the amount of the unrealized losses which was $0.3 million at September 30, 2017. At December 31, 2016, there was one holding in an unrealized loss position which was not deemed to be other-than-temporarily impaired due to the length of time that it had been consecutively in a loss position and our evaluation of issuer-specific and industry-specific considerations. This holding was a common stock and was impaired for seven consecutive months. The fair value of this holding exceeded its cost during the year ended December 31, 2016. At September 30, 2016, there were two holdings in unrealized loss positions that were not deemed to be other-than-temporarily impaired due to the length of time that they had been in a loss position and our evaluation of issuer-specific and industry-specific considerations. One of these investments was a closed-end fund with diversified holdings across multiple companies and industries that had been impaired for one month. The second holding was a common stock that had been impaired for four months. |